Allarity Therapeutics Has Priced Its Public Offering Of 2.44M Shares And Common Warrants To Purchase Up To 2.44M Shares At A Combined Price Of $4.50, For Gross Proceeds Of Approximately $11M
Portfolio Pulse from Benzinga Newsdesk
Allarity Therapeutics has priced its public offering of 2.44 million shares and common warrants to purchase up to 2.44 million shares at a combined price of $4.50, aiming to raise gross proceeds of approximately $11 million.
July 06, 2023 | 10:02 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Allarity Therapeutics' public offering of shares and warrants could dilute existing shareholders, potentially leading to a short-term decrease in stock price.
Public offerings often lead to stock dilution, which can decrease the value of existing shares. This could potentially lead to a short-term decrease in Allarity Therapeutics' stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100